Status:
COMPLETED
A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers
Lead Sponsor:
Martin Angst
Conditions:
Skin Diseases
Eligibility:
All Genders
21-60 years
Phase:
NA
Brief Summary
This study aims to establish a novel approach assisting the rational development of analgesic and anti-inflammatory drugs. In a first step we will test in healthy human volunteers whether proteins med...
Eligibility Criteria
Inclusion
- Age between 21-60. 2. Skin type II or III according to the classification of Fitzpatrick (II: fair skin, always burns, sometimes tans, III: medium skin, sometimes burns, always tans).\

Exclusion
- History of a significant systemic disease, a dermatological disease, bleeding disorder, or chronic pain.
- 2\. Consumption of analgesic drugs. 3. Hypersensitivity to sunlight.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00186563
Last Update
June 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305